Optogenetics

Optogenetics uses genetically encoded, light-sensitive ion channels and pumps (opsins) to control genetically specified neuron populations with light on a millisecond timescale. Channelrhodopsin-2 opens a cation channel under blue light to excite neurons; halorhodopsin and archaerhodopsin hyperpolarize and silence them. Cell-type specificity plus bidirectional, temporally precise control make optogenetics the workhorse of causal circuit neuroscience, letting researchers test whether a defined population is necessary or sufficient for a behavior.

Translation to humans as a therapy is limited: it requires viral delivery of a foreign opsin gene, an implanted light source, and it raises immune and long-term safety questions, while light penetrates only shallow tissue. The first human application is in vision restoration, where an opsin is expressed in surviving retinal cells and light is delivered through the eye. As a clinical neuromodulation tool for brain disorders it remains investigational.